GlassScriptPhysician profile
Jeffrey Mark Feldman
NPI 1689685828
$43,376.07
in general payments reported to CMS, 2019-2025
13 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of Pediatric Anesthesiology providers received nationally (typical 2025 total: $40.62).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,570 · 2022: $19K · 2023: $3,529 · 2024: $3,318 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,670 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,375 · Honoraria: $2,020 · Travel and Lodging: $1,752 · Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,670.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,375.00 |
| Honoraria | $2,020.00 |
| Travel and Lodging | $1,752.07 |
| Food and Beverage | $1,422.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $16,283.31 | 2022-2025 | |
| Becton, Dickinson and Company | $13,722.13 | 2021-2025 | |
| Draeger Medical Systems, INC | $5,600.00 | 2025 | Anesthesia |
| Edwards Lifesciences Corporation | $2,084.04 | 2024 | |
| Getinge USA Sales, LLC | $2,000.00 | 2022 | |
| Blink Device Company, LLC | $1,875.00 | 2025 | Twitchview Train of Four Monitor |
| Medtronic, INC. | $1,044.02 | 2021-2025 | Bis, Nellcor |
| Fresenius Kabi USA, LLC | $360.64 | 2022-2025 | Ivenix Infusion System |
| Otsuka America Pharmaceutical, INC. | $184.40 | 2024-2025 | Rexulti |
| Eagle Pharmaceuticals, INC. | $129.12 | 2024 | |
| Novo Nordisk INC | $56.15 | 2024 | |
| Convatec INC. | $22.93 | 2024 | |
| Opko Pharmaceuticals, LLC | $14.33 | 2023 | Rayaldee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Feldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.